Researchers have developed the world’s smallest ultrasound detector
“Honey, I shrunk the detector”
Since the development of medical ultrasound imaging in the 1950s, the core detection technology of ultrasound waves has primarily focused on using piezoelectric detectors, which convert the pressure from ultrasound waves into electric voltage. The imaging resolution achieved with ultrasound depends on the size of the piezoelectric detector employed. Reducing this size leads to higher resolution and can offer smaller, densely packed one or two dimensional ultrasound arrays with improved ability to discriminate features in the imaged tissue or material. However, further reducing the size of piezoelectric detectors impairs their sensitivity dramatically, making them unusable for practical application.
Silicon photonics technology is widely used to miniaturize optical components and densely pack them on the small surface of a silicon chip. While silicon does not exhibit any piezoelectricity, its ability to confine light in dimensions smaller than the optical wavelength has already been widely exploited for the development of miniaturized photonic circuits.
Researchers at TUM and Helmholtz Zentrum München capitalized on the advantages of those miniaturized photonic circuits and built the world’s smallest ultrasound detector: the silicon waveguide-etalon detector, or SWED. Instead of recording voltage from piezoelectric crystals, SWED monitors changes in light intensity propagating through the miniaturized photonic circuits.
“This is the first time that a detector smaller than the size of a blood cell is used to detect ultrasound using the silicon photonics technology”, says Rami Shnaiderman, developer of SWED. “If a piezoelectric detector was miniaturized to the scale of SWED, it would be 100 million times less sensitive.”
“The degree to which we were we able to miniaturize the new detector while retaining high sensitivity due to the use of silicon photonics was breathtaking”, says Prof. Vasilis Ntziachristos, head of the Chair of Biological Imaging and director of the Institute for Biological and Medical Imaging at Helmholtz Zentrum München. The SWED size is about half a micron (0,0005 millimeters). This size corresponds to an area that is at least 10,000 times smaller than the smallest piezoelectric detectors employed in clinical imaging applications. The SWED is also up to 200 times smaller than the ultrasound wavelength employed, which means that it can be used to visualize features that are smaller than one micrometer, leading to what is called super-resolution imaging.
As the technology capitalizes on the robustness and easy manufacturability of the silicon platform, large numbers of detectors can be produced at a small fraction of the cost of piezoelectric detectors, making mass production feasible. This is important for developing a number of different detection applications based on ultrasound waves. “We will continue to optimize every parameter of this technology – the sensitivity, the integration of SWED in large arrays, and its implementation in hand-held devices and endoscopes”, adds Shnaiderman.
“The detector was originally developed to propel the performance of optoacoustic imaging, which is a major focus of our research at TUM and Helmholtz Zentrum München. However, we now foresee applications in a broader field of sensing and imaging”, says Ntziachristos.
While the researchers are primarily aiming for applications in clinical diagnostics and basic biomedical research, industrial applications may also benefit from the new technology. The increased imaging resolution may lead to studying ultra-fine details in tissues and materials. A first line of investigation involves super-resolution optoacoustic (photoacoustic) imaging of cells and micro-vasculature in tissues, but the SWED could be also used to study fundamental properties of ultrasonic waves and their interactions with matter on a scale that was not possible before.
Shnaiderman, R., Wissmeyer, G., Ülgen, O. et al. A submicrometre silicon-on-insulator resonator for ultrasound detection. Nature 585, 372–378 (2020).
The Institute of Biological and Medical Imaging at Helmholtz Zentrum München, the Chair of Biological Imaging at TUM, and TranslaTUM – the Central Institute for Translational Cancer Research at TUM’s university hospital Klinikum Rechts der Isar, have contributed equally to this new technology.